Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/HVO stock hub

AIM/HVO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/HVOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

52.2M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/HVO

In the news

Latest news · AIM/HVO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-14.5

P25 -54.2P50 2.1P75 13.7

ROIC-8.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/HVO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

GBP

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	376
Employees Change	75%
Employees Change Percent	24.92
Enterprise value	GBX 52.7M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00B9275X97
Last refreshed	2026-05-10
Market cap	GBX 52.2M
Price	GBX 7.6
Price currency	GBX
Rev Per Employee	132,074.47x
Sector	Healthcare
Sic	8731
Symbol	aim/HVO
Website	https://www.hvivo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.48%
EV Earnings	-8.79x
EV/EBITDA	38.78x
EV/FCF	-3.33x
EV/Sales	1.06x
FCF yield	-30.29%
P/B ratio	1.37x
P/S ratio	1.05x
PE Ratio3 Y	13.09x
PE Ratio5 Y	12.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.52%
EBITDA Margin	-1.27%
Gross margin	2.86%
Gross Profit	GBX 1.4M
Gross Profit Growth	-86.72%
Gross Profit Growth3 Y	-55.89%
Gross Profit Growth5 Y	-34.75%
Net Income	GBX -6M
Net Income Growth Years	0%
Pretax Margin	-9.08%
Profit Margin	-12.07%
Profit Per Employee	GBX -15,939
ROA	-2.52
Roa5y	5
ROCE	-5.98
ROE	-14.47
Roe5y	13.49
ROIC	-8.37
Roic5y	310.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-57.32%
Cagr3y	-22.29%
Cagr5y	-25.1%
EPS Growth Years	0
Revenue Growth	-25x
Revenue Growth Q	-16.57x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.6x
Revenue Growth5 Y	-3.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.62
Assets	GBX 71.8M
Cash	GBX 14.3M
Current Assets	GBX 28.9M
Current Liabilities	GBX 17.7M
Debt	GBX 14.8M
Debt EBITDA	GBX 10.88
Debt Equity	GBX 0.39
Debt FCF	GBX -0.93
Equity	GBX 38.2M
Interest Coverage	-3.08
Liabilities	GBX 33.7M
Long Term Assets	GBX 42.9M
Long Term Liabilities	GBX 15.9M
Net Cash	GBX -490,000
Net Cash By Market Cap	GBX -0.94
Net Debt Equity	GBX 0.01
Tangible Book Value	GBX 19.3M
Tangible Book Value Per Share	GBX 0.03
WACC	11.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.63
Inventory Turnover	64.53
Net Working Capital	GBX -617,000
Quick ratio	1.51
Working Capital	GBX 11.2M
Working Capital Turnover	GBX 2.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.37%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	GBX 0
Dividend Years	3
Dividend Yield	0.03%
Ex Div Date	2025-05-15
Last Dividend	GBX 0
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-57.3%
200-day SMA	7.62
3Y total return	-53.07%
50-day SMA	7.74
50-day SMA vs 200-day SMA	50over200
5Y total return	-76.43%
All Time High	48
All Time High Change	-84.17%
All Time High Date	2021-04-12
All Time Low	4.31
All Time Low Change	76.54%
All Time Low Date	2025-12-11
ATR	0.64
Beta	1.69
Beta1y	1.99
Beta2y	1.08
Ch YTD	20.64
High	8.2
High52	18.5
High52 Date	2025-05-16
High52ch	-58.92%
Low	7.57
Low52	4.31
Low52 Date	2025-12-11
Low52ch	76.54%
Ma50ch	-1.76%
Price vs 200-day SMA	-0.3%
RSI	48.32
RSI Monthly	39.93
RSI Weekly	48.73
Sharpe ratio	-0.5x
Sortino ratio	-0.63
Total Return	0.4%
Tr YTD	20.64
Tr1m	10.15%
Tr1w	4.11%
Tr3m	24.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -3.2M
Operating margin	-6.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	569,624,544%
Net Borrowing	-3,198,000
Shares Insiders	1.98%
Shares Institutions	70.82%
Shares Out	687,014,088
Shares Qo Q	-0.28%
Shares Yo Y	-0.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -16.6M
Average Volume	4,779,063.2x
Bv Per Share	0.06
CAPEX	GBX -1.4M
Ch1m	10.15
Ch1w	4.11
Ch1y	-57.78
Ch3m	24.59
Ch3y	-53.94
Ch5y	-79.87
Ch6m	18.75
Change	-6.17%
Change From Open	-7.32
Close	8.1
Days Gap	1.23
Depreciation Amortization	2,605,000
Dollar Volume	17,628,618
Earnings Date	2026-04-15
EBIT	GBX -3.2M
EBITDA	GBX -631,000
EPS	GBX -0.01
F Score	1
FCF	GBX -15.8M
FCF EV Yield	-30.01x
FCF Per Share	GBX -0.02
Financing CF	-4,582,000
Fiscal Year End	December
Goodwill	13,901,000
Income Tax	GBX 1.5M
Investing CF	-10,865,000
Is Primary Listing	1
Last Earnings Date	2026-04-15
Last Report Date	2025-12-31
Ma150	6.94
Ma150ch	9.53%
Ma20	8.09
Ma20ch	-6.01%
Net CF	-29,883,000
Next Earnings Date	2026-06-23
Open	8.2
Payment Date	2025-06-11
Position In Range	4.76
Ppne	21,747,000
Price Date	2026-05-08
Ptbv Ratio	2.71
Relative Volume	0.49x
Revenue	49,660,000x
SBC By Revenue	1.64x
Share Based Comp	814,000
Tax By Revenue	2.99x
Tr6m	18.75%
Volume	2,319,555
Z Score	3.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

AIM/HVO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.0%

$0.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2025-05-15

Performance

AIM/HVO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/HVO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+70.8%

Share of float held by funds and institutions

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

AIM/HVO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.3

Neutral momentum band

Price vs 200-day MA

-0.3%

50/200-day relationship not available

Beta (5Y)

1.69

More volatile than the market

Sharpe ratio

-0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/HVO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/HVO stock rating?

aim/HVO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/HVO analysis?

The full report lives at /stocks/aim/HVO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/HVO?

The latest report frames aim/HVO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/HVO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.